| Literature DB >> 34066199 |
Paula Schorgg1,2, Till Bärnighausen2, Sabine Rohrmann3, Aedin Cassidy4, Nena Karavasiloglou3, Tilman Kühn2,4.
Abstract
Vitamin B6 from plant foods may have lower bioavailability than vitamin B6 from animal foods, but studies on objectively measured vitamin B6 status among vegetarians compared to non-vegetarians are lacking. Thus, the vitamin B6 status among vegetarians, but also pescatarians, and flexitarians, compared to meat-eaters was assessed in the population-based NHANES study (cycles 2007-2008 and 2009-2010). Data on serum pyridoxal-5'-phosphate (PLP) and 4-pyridoxic acid (4-PA) measured by high-performance liquid chromatography (HPLC) as well as dietary intakes from 24-h recalls were available for 8968 adults aged 20-80 years. Geometric mean (±standard error) PLP concentrations were 58.2 ± 6.0, 52.1 ± 3.7, 49.2 ± 4.6 and 51.0 ± 1.1 nmol/L among vegetarians, pescatarians, flexitarians, and meat-eaters. The 4-PA concentrations were 32.7 ± 4.0, 29.0 ± 2.5, 34.8 ± 5.6 and 33.0 ± 0.7, respectively. There were no statistically significant differences in PLP, 4-PA, and their ratio across the groups in multivariable linear regression models. Overall, the use of vitamin B6 supplements was the strongest predictor of the vitamin B6 status, followed by the dietary vitamin B6 intake. Interestingly, several other covariates were significantly associated with vitamin B6 biomarker levels, particularly serum albumin, creatinine and alkaline phosphatase, and should be considered when assessing the vitamin B6 status. In summary, our findings suggest that a vegetarian diet does not pose a risk for vitamin B6 deficiency.Entities:
Keywords: 4-pyridoxic acid; population-based; pyridoxal-5′-phosphate; vegetarian diet; vitamin B6
Year: 2021 PMID: 34066199 PMCID: PMC8150266 DOI: 10.3390/nu13051627
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure A1Characteristics and exclusion of study population. a Pyridoxal-5′-Phosphate; b 4-Pyridoxic Acid.
Survey-weighted general characteristics of NHANES 2007–2010 study participants following a meat-eating, flexitarian, pescatarian or vegetarian diet (n = 8968).
| Unweighted Participants Counts (Survey-Weighted Frequencies) | ||||
|---|---|---|---|---|
| Meat-Eaters | Flexitarians | Pescatarians | Vegetarians | |
| Age, mean a (SE) | 44.7 (0.4) | 47.4 (2.5) | 38.8 (1.8) | 37.1 (1.2) |
| Sex, n (%) | ||||
| Female | 4519 (51.6) | 69 (61.6) | 23 (65.7) | 35 (62.5) |
| Male | 4246 (48.4) | 43 (38.4) | 12 (34.3) | 21 (37.5) |
| Educational attainment, n (%) | ||||
| College or higher | 4229 (48.2) | 53 (47.3) | 23 (65.7) | 49 (87.5) |
| High school or lower | 4536 (51.8) | 59 (52.7) | 12 (34.3) | 7 (12.5) |
| Ethnicity, n (%) | ||||
| Mexican American | 1494 (17.0) | 21 (18.8) | 2 (5.7) | 5 (8.9) |
| Non-Hispanic Black | 1610 (18.4) | 17 (15.2) | 5 (14.3) | 2 (3.6) |
| Non-Hispanic White | 4427 (50.5) | 40 (35.7) | 21 (60.0) | 29 (51.8) |
| Other | 1234 (14.1) | 34 (30.4) | 7 (20.0) | 20 (35.7) |
| Body mass index (kg/m2), mean (SE) | 28.1 (0.1) | 26.1 (0.4) | 25.4 (0.7) | 24.9 (0.5) |
| Smoking status, n (%) | ||||
| Current smoker | 1884 (21.5) | 9 (8.0) | 3 (8.6) | 6 (10.7) |
| Former smoker | 2254 (25.7) | 29 (25.9) | 11 (31.4) | 11 (19.6) |
| Non-smoker | 4627 (52.8) | 74 (66.1) | 21 (60.0) | 39 (69.6) |
| Alcohol consumption, n (%) | ||||
| Binge or Heavy drinker | 2837 (32.4) | 24 (21.4) | 14 (40.0) | 15 (26.8) |
| Moderate drinker | 2686 (30.6) | 24 (21.4) | 9 (25.7) | 18 (32.1) |
| Non drinker | 1654 (18.9) | 26 (23.2) | 5 (14.3) | 6 (10.7) |
| Unknown/missing | 1588 (18.1) | 38 (33.9) | 7 (20.0) | 17 (30.4) |
| Physical activity, n (%) | ||||
| Moderate or vigorous | 3969 (45.3) | 43 (38.4) | 25 (71.4) | 35 (62.5) |
| None | 4796 (54.7) | 69 (61.6) | 10 (28.6) | 21 (37.5) |
| Vitamin B6 vitamers, mean (SE) | ||||
| PLP b (nmol/L) | 51.0 (1.1) | 49.2 (4.6) | 52.1 (3.7) | 58.2 (6.0) |
| 4-PA c (nmol/L) | 33.0 (0.7) | 34.8 (5.6) | 29.0 (2.5) | 32.7 (4.0) |
| Ratio, 4-PA/PLP | 0.6 (0.01) | 0.7 (0.1) | 0.6 (0.02) | 0.6 (0.03) |
| Dietary vitamin B6 Supplement Use d, n (%) | ||||
| No | 5975 (68.2) | 79 (70.5) | 22 (62.9) | 31 (55.4) |
| Yes | 2790 (31.8) | 33 (29.5) | 13 (37.1) | 25 (44.6) |
| Dietary vitamin B6 Intake (mg/d), mean (SE) | 1.8 (0.02) | 1.6 (0.1) | 1.6 (0.1) | 1.7 (0.05) |
| Total e vitamin B6 Intake (mg/d), mean (SE) | 2.8 (0.1) | 2.5 (0.3) | 3.3 (0.9) | 2.9 (0.3) |
a Mean values are geometric mean values; b PLP = pyridoxal-5′-phosphate; c 4-PA = 4-pyridoxic acid; d includes vitamin B6 from multivitamin and micronutrient preparations; e Total vitamin B6 intake includes dietary and supplementary vitamin B6.
Survey-weighted food group consumption of NHANES 2007–2010 study participants following a meat-eating, flexitarian, pescatarian or vegetarian diet.
| Unweighted Participants Counts (Survey-Weighted Frequencies) | ||||
|---|---|---|---|---|
| Meat-Eaters | Flexitarians | Pescatarians | Vegetarians | |
| Dietary intake, median (IQR) | ||||
| Meat (oz. eq.) | 1.2 (2.5) | 0.2 (1.2) | 0.0 (0.0) | 0.0 (0.0) |
| Seafood (oz. eq.) | 0.0 (0.3) | 0.0 (0.2) | 0.4 (0.9) | 0.0 (0.0) |
| Poultry (oz. eq.) | 1.0 (2.4) | 0.7 (1.7) | 0.0 (0.0) | 0.0 (0.0) |
| Fruit (cup eq.) | 0.7 (1.4) | 0.9 (1.2) | 1.0 (1.3) | 1.1 (1.8) |
| Vegetables and legumes a (cup eq.) | 0.5 (0.5) | 0.6 (0.6) | 0.7 (0.6) | 0.7 (0.9) |
| Dairy (cup eq.) | 1.4 (1.4) | 1.0 (1.2) | 1.2 (1.7) | 1.3 (1.7) |
| Eggs (oz. eq.) | 0.2 (0.8) | 0.2 (0.7) | 0.1 (0.7) | 0.1 (0.2) |
| Dietary fiber (g/d) | 15.2 (10.1) | 15.8 (14.0) | 22.8 (14.7) | 22.4 (18.2) |
a Legumes include starchy and protein computed legume.
Survey-weighted serum parameters of NHANES 2007–2010 study participants following a meat-eating, flexitarian, pescatarian or vegetarian diet (n = 8885 a).
| Unweighted Participants Counts (Survey-Weighted Frequencies) | ||||
|---|---|---|---|---|
| Meat-Eaters | Flexitarians | Pescatarians | Vegetarians | |
| Serum parameters, mean b (SE) | ||||
| C-reactive protein(mg/dL) | 0.2 (0.004) | 0.1 (0.01) | 0.1 (0.02) | 0.1 (0.02) |
| Cotinine (ng/mL) | 0.3 (0.03) | 0.1 (0.04) | 0.1 (0.02) | 0.2 (0.1) |
| Glycosylated hemoglobin (%) | 5.6 (0.01) | 5.7 (0.07) | 5.3 (0.04) | 5.4 (0.045) |
| Albumin (g/dL) | 4.3 (0.007) | 4.3 (0.03) | 4.2 (0.1) | 4.3 (0.046) |
| Creatinine (mg/dL) | 0.9 (0.005) | 0.8 (0.02) | 0.7 (0.02) | 0.8 (0.02) |
| Alkaline phosphotase (U/L) | 64.1 (0.3) | 64.1 (2.9) | 62.3 (4.6) | 60.3 (2.4) |
a Due to missing biomarker values among 83 participants overall (n missing for CRP = 9, cotinine = 23, glycosylated hemoglobin = 15, albumin = 62, creatinine = 63, alkaline phosphatase = 63) Model 2 included data of 8885 participants. b Mean values are geometric mean values.
Figure 1Geometric mean values of PLP (pyridoxal-5’-phosphate) and 4-PA (4-pyridoxic acid) serum concentrations (nmol/L), their ratio, and total vitamin B6 intake (mg/d) of study participants following a meat-eating, flexitarian, pescatarian or vegetarian diet. PModel 1/PModel 2: p–values shown for overall differences across all groups from linear regression Models 1 and 2; the only pairwise differences between groups that were statistically significant were those in vitamin B6 intake between vegetarians and non-vegetarians at p-values of 0.0027 and <0.0001 in Model 1 and Model 2, respectively. Model 1 *: Adjusted for age, sex and fasting duration before blood draw; Model 2 *: further adjusted for educational attainment, ethnicity, body mass index, smoking status, alcohol consumption, physical activity, diabetes mellitus prevalence, cancer prevalence, cardiovascular disease prevalence, vitamin B6 supplement use, dietary vitamin B6 intake, liver condition prevalence, current oral contraceptive use, menopausal status, prescription drug usage (theophylline, l-dopamine, non-steroidal anti-inflammatory drugs, COX2-inhibitors, isoniazid and hydralazine), and serum parameters (C-reactive protein (CRP), cotinine, glycosylated hemoglobin, albumin, creatinine, alkaline phosphatase). Due to missing biomarker values among 83 participants overall (n missing for CRP = 9, cotinine = 23, glycosylated hemoglobin = 15, albumin = 62, creatinine = 63, alkaline phosphatase = 63) Model 2 included data of 8885 participants. * Models on dietary vitamin B6 not adjusted for fasting duration; Table A3 (Appendix A) further shows adjusted geometric mean vitamin B6 vitamer serum concentrations obtained by the least squares means method.
Adjusted geometric mean vitamin B6 vitamer serum concentrations of study participants following a meat-eating, flexitarian, pescatarian or vegetarian diet a.
| Meat-Eaters | Flexitarians | Pescatarians | Vegetarians | ||
|---|---|---|---|---|---|
| Model 1 | |||||
| PLP c, mean ± SE | 51.1 ± 1.0 | 50.2 ± 1.1 | 54.7 ± 1.1 | 59.6 ± 1.2 | 0.51 |
| 4-PA d, mean ± SE | 34.7 ± 1.0 | 34.4 ± 1.2 | 35.0 ± 1.2 | 41.2 ± 1.2 | 0.76 |
| Ratio, 4-PA/PLP, mean ± SE | 2.6 ± 1.0 | 3.4 ± 1.3 | 2.4 ± 1.1 | 2.6 ± 1.0 | 0.67 |
| Model 2 | |||||
| PLP, mean ± SE | 70.1 ± 1.2 | 69.2 ± 1.2 | 64.5 ± 1.3 | 69.4 ± 1.2 | 0.96 |
| 4-PA, mean ± SE | 76.4 ± 1.4 | 82.5 ± 1.3 | 67.1 ± 1.4 | 81.0 ± 1.4 | 0.73 |
| Ratio, 4-PA/PLP, mean ± SE | 5.9 ± 1.8 | 8.0 ± 1.9 | 6.1 ± 1.8 | 6.4 ± 1.8 | 0.56 |
a Mean values obtained by the least squares means method from multivariable adjusted linear regression models; b p-value for overall differences across groups from linear regression models; none of the pairwise between-group comparisons showed differences at p < 0; c PLP = pyridoxal-5′-phosphate; d 4-PA = 4-pyridoxic acid. Model 1: Adjusted for age, sex and fasting duration before blood draw. Model 2: Adjusted for age, sex, fasting duration before blood draw, educational attainment, ethnicity, body mass index, smoking status, alcohol consumption, physical activity, diabetes mellitus prevalence, cancer prevalence, cardiovascular disease prevalence, vitamin B6 supplement use, dietary vitamin B6 intake, liver condition prevalence, current oral contraceptive use, menopausal status, prescription drug usage (theophylline, l-dopamine, non-steroidal anti-inflammatory drugs, COX2-inhibitors, isoniazid and hydralazine), and serum parameters (C-reactive protein (CRP), cotinine, glycosylated hemoglobin, albumin, creatinine, alkaline phosphatase). Due to missing biomarker values among 83 participants overall (n missing for CRP = 9, cotinine = 23, glycosylated hemoglobin = 15, albumin = 62, creatinine = 63, alkaline phosphatase = 63) Model 2 included data of 8885 participants.
Survey-weighted categories of vitamin B6 supply across NHANES 2007–2010 study participants following a vegetarian, pescatarian, flexitarian and meat-eating diet based on PLP a serum concentrations (n = 8968).
| Unweighted Participants Counts (Survey-Weighted Frequencies) | ||||
|---|---|---|---|---|
| Meat-Eaters | Flexitarians | Pescatarians | Vegetarians | |
| Categories, n (%) | ||||
| Adequate | 5987 (68.3) | 83 (74.1%) | 28 (80.0%) | 42 (75.0%) |
| Moderately deficient | 1487 (17.0) | 16 (14.3%) | 5 (14.3%) | 5 (8.9%) |
| Deficient | 1291 (14.7) | 13 (11.6%) | 2 (5.7%) | 9 (16.1%) |
a PLP = pyridoxal-5′-phosphate.
Predictors of vitamin B6 vitamer serum concentrations (n = 8885) a.
| Pyridoxal-5′-Phosphate | 4-Pyridoxic Acid | Ratio, 4-PA/PLP | ||||
|---|---|---|---|---|---|---|
| R2 |
| R2 |
| R2 |
| |
| Diet Type | <0.1 | 0.96 | <0.1 | 0.73 | <0.1 | 0.56 |
| Age | <0.1 | 0.16 | 2.1 | <0.0001 | 0.1 | 0.003 |
| Sex | 0.1 | 0.44 | 0.8 | 0.06 | 1.6 | 0.003 |
| Fasting duration | 0.3 | 0.0013 | 1.2 | <0.0001 | 0.3 | <0.0001 |
| Vitamin B6 supplement use | 18.1 | <0.0001 | 18.5 | <0.0001 | 0.7 | <0.0001 |
| Dietary vitamin B6 intake | 5.4 | <0.0001 | 4.2 | <0.0001 | <0.1 | 0.91 |
| Body mass index | 0.7 | <0.0001 | 0.3 | 0.0008 | 0.1 | 0.04 |
| Educational attainment | <0.1 | 0.055 | <0.1 | 0.30 | <0.1 | 0.38 |
| Ethnicity | 0.2 | <0.0001 | 1.5 | <0.0001 | 0.2 | 0.002 |
| Smoking status | 0.1 | 0.14 | <0.1 | 0.38 | 0.1 | 0.07 |
| Alcohol consumption | 0.1 | 0.06 | 0.1 | 0.31 | <0.1 | 0.29 |
| Physical activity | 0.2 | 0.01 | <0.1 | 0.24 | 0.1 | 0.02 |
| Prevalent diabetes mellitus | 0.2 | 0.001 | 0.1 | 0.32 | 0.3 | 0.02 |
| History of cancer | 0.1 | 0.11 | <0.1 | 0.92 | <0.1 | 0.33 |
| History cardiovascular diseases | <0.1 | 0.23 | <0.1 | 0.10 | 0.1 | 0.02 |
| Prevalent liver disease | 0.1 | 0.08 | <0.1 | 0.34 | <0.1 | 0.02 |
| Oral contraceptive use | 0.1 | 0.03 | 0.1 | 0.35 | <0.1 | 0.10 |
| Menopausal status | 0.8 | <0.0001 | 0.1 | 0.04 | 0.1 | 0.24 |
| Prescription drug use | ||||||
| Theophylline | 0.1 | 0.0015 | <0.1 | 0.15 | 0.4 | 0.02 |
| L-Dopamin | <0.1 | 0.30 | <0.1 | 0.08 | <0.1 | 0.18 |
| NSAID | <0.1 | 0.25 | <0.1 | 0.64 | <0.1 | 0.43 |
| COX2 Inhibitors | 0.1 | 0.006 | 0.1 | 0.01 | <0.1 | 0.31 |
| Isoniazid | 0.1 | 0.0001 | 0.1 | <0.0001 | <0.1 | 0.93 |
| Hydralazine | <0.1 | 0.27 | <0.1 | 0.71 | <0.1 | 0.32 |
| Serum parameters | ||||||
| C-reactive protein | 0.2 | 0.0096 | <0.1 | 0.22 | 0.1 | <0.0001 |
| Cotinine | 0.7 | <0.0001 | 0.5 | <0.0001 | <0.1 | 0.25 |
| Glycohemoglobin | 0.1 | 0.02 | 0.1 | 0.007 | 0.2 | 0.002 |
| Albumin | 3.4 | <0.0001 | 0.1 | 0.10 | 1.0 | <0.0001 |
| Creatinine | 0.3 | 0.0002 | 5.0 | <0.0001 | 8.2 | <0.0001 |
| Alkaline phosphatase | 4.0 | <0.0001 | 0.1 | 0.04 | 0.8 | <0.0001 |
| Model R2 | 40.98 | 39.33 | 16.50 | |||
a Semi-partial R2 values from a multivariable linear regression model mutually adjusted for all variables in the table. Due to missing biomarker values among 83 participants (n missing for CRP = 9, cotinine = 23, glycosylated hemoglobin = 15, albumin = 62, creatinine = 63, alkaline phosphatase = 63) Model 2 included data of n = 8885 participants.